Stimulator, Nerve, Electrical, Transcutaneous, For Migraine
FDA product code PCC · 17 cleared devices
Class 2
Neurology
- Regulation
- 21 CFR 882.5891
- Review panel
- NE
- Implant
- No
- Life sustaining
- No
- Third party review
- No
- GMP exempt
- No
- Clearance span
- 2016-03-04 – 2026-04-16
Used to apply an electrical current to a patient's cranium through electrodes placed on the skin.
PCC
2026-04-16
PCC
2024-11-06
ELEXIR 2.0 (ALLIVE3)
View details →
PCC
2024-07-18
CEFALY Connected - OTC, CEFALY Connected - Rx
View details →
PCC
2024-06-11
DOOPANG
View details →
PCC
2024-06-03
Milieve (YPS-301BD)
View details →
PCC
2024-02-26
TENS device-HeadaTerm 2 (Model: YF-HT2)
View details →
PCC
2022-12-13
Cefaly Dual Enhanced with RFID - OTC, Cefaly Dual Enhanced with RFID - Rx, Cefaly Dual Connected - OTC, Cefaly Dual Connected - Rx
View details →
PCC
2021-08-02
Relivion
View details →
PCC
2021-07-30
Elexir
View details →
PCC
2021-06-17
Migraine Tens Digital Pain Reliever
View details →
PCC
2021-02-16
Relivion
View details →
PCC
2020-09-29
Cefaly Dual
View details →
PCC
2019-12-06
ALLIVE
View details →
PCC
2018-09-13
TENS device-HeadaTerm, eEspress
View details →
PCC
2017-11-28
Cefaly Dual
View details →
PCC
2017-09-15
Cefaly Acute
View details →
PCC
2016-03-04
Cefaly
View details →No matching devices.
Advertisement